Chinese Journal of Clinical Oncology

, Volume 2, Issue 3, pp 679–684 | Cite as

Anti-tumor effect of CDA-II on a human glioma cell

  • Hongyan Wang
  • Xueyun Zhong
  • Frank C. Liu
  • Yanfang Qin
Original Articles

Abstract

Objective

To examine the effect of uroacitide (CDA-II ), an extraction product from normal human urine, on proliferation and differentiation of human glioma SWO-38 cells.

Methods

The effects of CDA-II on cellular survival and colony formation were determined by MTT and colony-formation assays. The in vivo anti-tumor effect of CDA-II was examined on transplanted SWO-38 cells in nude mice. In addition, the aterations in cell morphology induced by CDA-II were observed by H&E staining.

Results

Treatment of SWO-38 cells with 1–5 mg/ml of CDA-II for 3 days, resulted in 39.49%± 5.27%~65.05%± 5.89% growth inhibition with an IC50of 2.52 mg/ml. Based on the colony-formation assay, 10 days of CDA-II treatment at a level of 0.3~2.1 mg/ml caused 23.45%± 0.62%~96.22%±1.01% inhibition with an IC50 of 1.03 mg/ml. Furthermore, the inhibitory response was dose-dependent. CDA-II at dosage of 500 mg/kg or 2,000 mg/kg per day for 4 weeks significantly suppressed the growth of human glioma SWO-38 cells in nude mice, with inhibition being 47.77% and 79.94%, respectively (P< 0.05, n=10). H&E staining and light microscopy revealed that CDA-II induced differentiation of the SWO-38 cells.

Conclusion

CDA-II has a significant anti-tumor effect on the human glioma SWO-38 cells, and is a potential and natural anti-glioma therapeutic reagent.

Keywords

CDA-II glioma anti-tumor effect proliferation induced differentiation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mizunno M, Yoshida J. Tumor necrosis factor-α gene transfer augments anti-fas antibody-mediated apoptosis in human glioma cell. Jpn Cancer Res. 1996, 87:543–547.Google Scholar
  2. 2.
    Liao MC. A clever anticancer drug CDA-H. Taipei: ShiMao publisher. 1999; 149–161.Google Scholar
  3. 3.
    Zhong XY, Chen YX, Ye SF, et al. Establishment of two cell sublines from SWO-38 glioma cells: an immunohisto-chemical and ultrastructural Study. Int J Modern Cancer Therapy. 2000; 3:34–37.Google Scholar
  4. 4.
    Marcantonio D, Panasci LC, Hollingshead MG, et al. 2-Chloroethyl-3-sarcosinam ide-1-nitrosourea, a novel chloroethyl nitrosourea analogue with enhanced antitumor activity against human glioma xenografs. Cancer Res. 1997; 57:3895–3898.PubMedGoogle Scholar
  5. 5.
    Skapek SX, Vandellen AF, McMahon DP, et al. Melphalaninduced toxicity in nude mice following pretreatment with buthionine sulfoximine. Cancer Chem Pharmacol. 1991; 28: 15–21.CrossRefGoogle Scholar
  6. 6.
    Sato etol. Eradicate cancer. Taipei: ShiMao publisher. 1997; 226–231.Google Scholar
  7. 7.
    Burynski SR. Antineoplastons: History of the research (1). Drugs Exp Clin Res. 1986; 12:1–9.Google Scholar
  8. 8.
    Feng PY, Li Q, Wang ZJ, et al. The clinic study of CDA-H improve life quality of terminal malignancy patient. China Cancer. 2002; 11:108–200.Google Scholar
  9. 9.
    Burzynski SR, Lewy RI, Weaver RA, et al. Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report. Drugs R&D. 2003; 4:91–101.CrossRefGoogle Scholar
  10. 10.
    Liu JW, Tang Y, Shen Y, et al. Antitumor effect of arsenic trioxide in combination with uroacitides on hepatocellular carcinoma. Chin J Gen Surg. 2003; 18:114–116.Google Scholar
  11. 11.
    Liu JW, Tang Y, Shen Y, et al. Apoptosis threshold of hepatoma cell lines induced by As2O3 and CDA-II. Chin J Exp Surg. 2003; 20:116–117.Google Scholar
  12. 12.
    Liu JW, Tang Y, Shen Y, et al. Synergistic effect of cell differentiation agent II and arsenic trioxide on induction of cell cycle and apoptosis in hepatotumor cells. World J Gastroentero. 2003; 9:65–68.Google Scholar
  13. 13.
    Lin WC, Wu YW, Lai TY, et al. Effect of CDA-II, urinary preparation, on lipofuscin, lipid peroxidation and antioxidant systems in young and middle-aged rat brain. Am J Chin Med. 2001; 29:91–99.PubMedCrossRefGoogle Scholar
  14. 14.
    Natarajan V, Scribner WM, Al-Hassani M, et al. Reactive oxygen species signaling through regulation of protein tyrosine phos-phorylation in endothelial cells. Environ Health Perspect. 1998; 106:1205–1212.PubMedCrossRefGoogle Scholar

Copyright information

© Chinese Anti-Cancer Association and Springer 2003

Authors and Affiliations

  • Hongyan Wang
    • 1
  • Xueyun Zhong
    • 1
  • Frank C. Liu
    • 1
  • Yanfang Qin
    • 1
  1. 1.Department of PathologyMedical College of Jinan UniversityGuangzhouChina

Personalised recommendations